drugset
drugset / Trial / NCT01434849

Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)

NCT01434849 ↗

Phase 1 Terminated 26 enrolled Alice K. Gong
RandomizedSingle-groupQuadruple-blindPrevention

Summary

The purpose of this trial is to see if a topical beta blocker is effective in preventing the proliferation of infantile hemangioma.

Timeline

Start
2012-07
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Timolol Other / unclassified 0.5 % Topical

Indications

hemangioma